99 related articles for article (PubMed ID: 1441595)
1. Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine.
Pfandl B; Mörike K; Winne D; Schareck W; Breyer-Pfaff U
Xenobiotica; 1992 Jun; 22(6):721-30. PubMed ID: 1441595
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline.
Dahl ML; Nordin C; Bertilsson L
Ther Drug Monit; 1991 May; 13(3):189-94. PubMed ID: 1926270
[TBL] [Abstract][Full Text] [Related]
3. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960
[TBL] [Abstract][Full Text] [Related]
4. E- and Z-10-hydroxylation of nortriptyline by human liver microsomes--methods and characterization.
Mellström B; Bertilsson L; Birgersson C; Göransson M; von Bahr C
Drug Metab Dispos; 1983; 11(2):115-9. PubMed ID: 6133714
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver.
Breyer-Pfaff U; Nill K
Xenobiotica; 1995 Dec; 25(12):1311-25. PubMed ID: 8719907
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
7. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
8. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
Nordin C; Bertilsson L
Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
[TBL] [Abstract][Full Text] [Related]
10. The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population.
Halling J; Weihe P; Brosen K
Br J Clin Pharmacol; 2008 Jan; 65(1):134-8. PubMed ID: 17764479
[TBL] [Abstract][Full Text] [Related]
11. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans.
Abolfathi Z; Fiset C; Gilbert M; Moerike K; Bélanger PM; Turgeon J
J Pharmacol Exp Ther; 1993 Sep; 266(3):1196-201. PubMed ID: 8371133
[TBL] [Abstract][Full Text] [Related]
12. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
13. Glucuronides of hydroxylated metabolites of amitriptyline and nortriptyline isolated from rat bile.
Baier-Weber B; Prox A; Wachsmuth H; Breyer-Pfaff U
Drug Metab Dispos; 1988; 16(3):490-6. PubMed ID: 2900745
[TBL] [Abstract][Full Text] [Related]
14. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report.
Vandamme N; Broly F; Libersa C; Courseau C; Lhermitte M
J Cardiovasc Pharmacol; 1993 Jan; 21(1):77-83. PubMed ID: 7678683
[TBL] [Abstract][Full Text] [Related]
17. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
Muralidharan G; Hawes EM; McKay G; Midha KK
Xenobiotica; 1991 Nov; 21(11):1441-50. PubMed ID: 1763518
[TBL] [Abstract][Full Text] [Related]
18. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
[TBL] [Abstract][Full Text] [Related]
19. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.
Hou ZY; Chen CP; Yang WC; Lai MD; Buchert ET; Chung HM; Pickle LW; Woosley RL
Clin Pharmacol Ther; 1996 Apr; 59(4):411-7. PubMed ID: 8612385
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of quinidine by human liver cytochrome P-450.
Guengerich FP; Müller-Enoch D; Blair IA
Mol Pharmacol; 1986 Sep; 30(3):287-95. PubMed ID: 3748010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
